IRIS
GRASSADONIA, Antonino
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.967
EU - Europa 2.774
AS - Asia 1.378
SA - Sud America 22
OC - Oceania 17
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 5
Totale 7.172
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.955
IT - Italia 546
IE - Irlanda 539
SG - Singapore 527
CN - Cina 485
SE - Svezia 359
UA - Ucraina 336
FR - Francia 313
GB - Regno Unito 242
TR - Turchia 221
DE - Germania 168
IN - India 77
RU - Federazione Russa 73
FI - Finlandia 67
VN - Vietnam 41
BE - Belgio 32
CZ - Repubblica Ceca 29
PL - Polonia 22
BR - Brasile 20
AU - Australia 13
CA - Canada 11
LT - Lituania 9
TW - Taiwan 8
AT - Austria 7
HK - Hong Kong 6
RO - Romania 6
EG - Egitto 5
ES - Italia 5
EU - Europa 5
NL - Olanda 5
CH - Svizzera 4
NZ - Nuova Zelanda 4
JP - Giappone 3
PT - Portogallo 3
GR - Grecia 2
IL - Israele 2
KR - Corea 2
LU - Lussemburgo 2
MA - Marocco 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
BG - Bulgaria 1
DK - Danimarca 1
DZ - Algeria 1
ID - Indonesia 1
IQ - Iraq 1
IR - Iran 1
LV - Lettonia 1
MX - Messico 1
PK - Pakistan 1
PY - Paraguay 1
SC - Seychelles 1
SI - Slovenia 1
UZ - Uzbekistan 1
Totale 7.172
Salva come PNG Salva come JPEG
Città #
Chandler 656
Dublin 528
Singapore 458
Jacksonville 435
Princeton 203
Southend 166
Izmir 132
Ashburn 128
Nanjing 128
Beijing 102
Santa Clara 95
Chieti 91
Ann Arbor 84
Dearborn 84
Wilmington 84
Altamura 83
Boardman 66
Cambridge 62
Los Angeles 45
Dong Ket 40
New York 39
Nanchang 37
Pescara 37
Brussels 32
Munich 32
Woodbridge 28
Washington 27
Rome 24
Brno 23
Hebei 22
Kunming 21
Shenyang 21
Tianjin 20
Norwalk 19
Jiaxing 18
Kraków 18
Falls Church 14
Milan 14
Changsha 13
Helsinki 13
Grevenbroich 11
Houston 11
Hangzhou 9
Guangzhou 8
Bristol 7
Changchun 7
Frankfurt am Main 7
London 7
Melbourne 7
Nuremberg 7
Tappahannock 7
Augusta 6
Chicago 6
Corridonia 6
Hefei 6
Lanciano 6
Menlo Park 6
Oklahoma City 6
Seattle 6
Taipei 6
Ascoli Piceno 5
Auburn Hills 5
Cairo 5
Edinburgh 5
Jinan 5
Lanzhou 5
Lappeenranta 5
Moscow 5
Romola 5
Carini 4
Denver 4
Garden City 4
Loma Linda 4
L’Aquila 4
Montorio al Vomano 4
Napoli 4
Ottawa 4
Penne 4
Spoltore 4
Ameno 3
Amsterdam 3
Aprilia 3
Aquila 3
Collecorvino 3
Madrid 3
Montesilvano Marina 3
Mumbai 3
Ningbo 3
Olomouc 3
Perego 3
Perth 3
Pune 3
San Mateo 3
San Vito Chietino 3
Savigliano 3
Scarborough 3
Shanghai 3
Simi Valley 3
Sulmona 3
Vienna 3
Totale 4.432
Salva come PNG Salva come JPEG
Nome #
Breast cancer "tailored follow-up" in Italian oncology units: A web-based survey 119
The 90K protein increases major histocompatibility complex class I expression and is regulated by hormones, gamma-interferon, and double-strand polynucleotides. 111
New Targets for Therapy in Pancreatic Cancer 109
90K (Mac-2 BP) and galectins in tumor progression and metastasis. 107
A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancer. 102
A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer 102
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting 100
Occupational allergy: is there a role for nanoparticles? 99
High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies 97
The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Pancreatic Cancer 97
Glicomimetici quali potenziali nuovi farmaci per la prevenzione delle metastasi. 96
The flavonoid quercetin inhibits thyroid-restricted genes expression and thyroid function. 94
Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With Eribulin 94
Impact of BMI on clinical outcome in advanced cancer patients treated with anti‑PD‑1 Immune checkpoint inhibitors: a preliminary analysis 93
Resveratrol inhibits sodium/iodide symporter gene expression and function in rat thyroid cells 92
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience 92
The Role of the Environment and Type of Exercise on Acute Adrenal Modulation and Perceived Distress of Breast Cancer Survivors Practising Light-Intensity Physical Exercise 92
Gli analoghi sintetici delle glicoamine come potenziali nuovi farmaci nella prevenzione delle metastasi 91
An Epigenetic Approach to Pancreatic Cancer Treatment: the Prospective Role of Histone Deacetylase Inhibitors 90
Long-term outcome of neoadjuvant endocrine therapy with aromatase inhibitors in elderly women with hormone receptor-positive breast cancer 90
Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation 90
Upstream stimulatory factor regulates constitutive expression and hormonal suppression of the 90K (Mac-2BP) protein. 89
Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody. 89
Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients 89
A phase I study of 5-day continuous venous infusion of carboplatin (CBDCA) at circadian rhythm-modulated rate 88
A Case of Stage I Vulvar Squamous Cell Carcinoma with Early Relapse and Rapid Disease Progression 88
Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials 87
A novel serum test using interferon for early detection of tumor reccurrence in cancer patients after radical surgery. 86
Long-term outcome of neoadjuvant systemic therapy for locally advanced breast cancer in routine clinical practice. 86
Principali effetti collaterali delle terapie mediche 86
Exosomes as pleiotropic players in pancreatic cancer 86
Analisi dello stato mutazionale di K-RAS: un nuovo strumento per la selezione dei pazienti candidati a terapia con anticorpi anti-EGFR 85
Do cut-off values of lymph node ratio and presence of perineural invasion affect survival in breast cancer patients with pathologic N3a lymph node stage? Reply to Kadri Altundag 85
Relief of symptoms after gefitinib is associated with improvement of rest/activity rhythm in advanced lung cancer 82
90k is a serum marker of poor-prognosis in non-hodgkins-lymphoma patients. 82
Identification of Subgroups of Early Breast Cancer Patients at High Risk of Nonadherence to Adjuvant Hormone Therapy: Results of an Italian Survey 80
A phase I study of 5-day continuous venous infusion of carboplatin (CBDCA) at circadian rhythm-modulated rate 79
Expression of the 90K tumor-associated protein in benign and malignant melanocytic lesions. 79
Tumor-derived microvesicles: The metastasomes. 79
Fulvestrant 500 milligrams as endocrine therapy for endocrine sensitive advanced breast cancer patients in the real world: the Ful500 prospective observational trial. 79
Long-term outcome of breast cancer patients with pathologic N3a lymph node stage 79
Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies 77
TGF-β-1 increases 90K tumor associated antigen gene expression by increasing upstream regulatory factor binding to the minimal promoter. 76
LGALS3BP, A TUMOR-ASSOCIATED ANTIGEN, UPREGULATES VEGF IN HUMAN BREAST CANCER: POSSIBLE IMPLICATIONS IN ANGIOGENESIS 76
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study 76
La stimolazione dinamica con IFN-α per la diagnosi precoce di ripresa di malattia in pazienti NED 75
BIOLOGICAL INDICATORS OF PROGNOSIS IN HUMAN CANCER: AN EMERGING ROLE FOR LECTIN GALACTOSIDE-BINDING SOLUBLE 3-BINDING PROTEIN (LGALS3BP) 75
Regolazione, funzione ed espressione genica dell’antigene tumore-associato 90K/AC-2 BP 73
Preoperative dose-dense sequential chemotherapy of epirubicin/cyclophosphamide followed by docetaxel/capecitabine in patients with breast cancer 73
Effect of targeted agents on the endocrine response of breast cancer in the neoadjuvant setting: A systematic review 72
Is the skin a sanctuary for breast cancer cells during treatment with anti-HER2 antibodies? 72
Circadian timing of chemotherapeutic agents:a phase II study of 5-fluoro-2-deoxyuridine in gastrointestinal cancer and renal cell carcinoma 71
Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer 71
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 71
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 70
Inhibition of tumor growth and angiogenesis by SP-2, an anti-LGALS3BP antibody 69
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 69
Neoadjuvant Chemotherapy for Surgically Staged IIIA N2 Non-Small Cell Lung Cancer (NSCLC) in the Elderly 68
Neoadjuvant Sequential Docetaxel Followed by High-Dose Epirubicin in Combination With Cyclophosphamide Administered Concurrently With Trastuzumab. The DECT Trial 68
Impact of Body Mass Index (BMI) on outcome of metastatic breast cancer (MBC) patients (pts) treated with Eribulin in a real-world population: a multicenter retrospective study 65
Corrigendum to "Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation" 65
Possible role of thymidylate synthase level in hunan colorectal carcinoma: a new prognostic factor? 64
Thyroglobulin regulates follicular function and heterogeneity by suppressing thyroid-specific gene expression. 64
Thyroglobulin autoregulation of thyroid-specific gene expression and follicular function 64
Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: A retrospective multicenter study 64
Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab 62
Infusione cronomodulata di farmaci in oncologia 61
Oral etoposide and platinum derivates in the treatment of metastatic Merkel cell carcinoma: report of three cases 61
Optimizing the Choice for Adjuvant Chemotherapy in Gastric Cancer 59
Prognostic value of a novel interferon-inducible 90K tumor antigen 59
Alectinib induced regression of renal and hepatic cysts caused by crizotinib 59
Chemotherapy-induced nausea and vomiting in Italian cancer centers: results of CINVDAY, a prospective, multicenter study. 58
Thymidylate synthase level and DNA-ploidy pattern as possible prognostic factors in human colorectal cancer: a preliminary study 57
Drug repurposing, an attractive strategy in pancreatic cancer treatment: Preclinical and clinical updates 57
Palliative radiotherapy in advanced cancer patients treated with immune-checkpoint inhibitors: The PRACTICE study 56
Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting 56
Blood Circulating CD133+ Extracellular Vesicles Predict Clinical Outcomes in Patients with Metastatic Colorectal Cancer 55
Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer 55
FPSE-HPLC-DAD metod for the quantification of anticancer drugs in human whole blood, plasma and urine 55
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients 55
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 55
Effect of taxanes following anthracyclines on pathologic complete response (pCR) in patients with triple-negative breast cancer (TNBC) receiving primary systemic therapy (PST). 54
Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score 54
The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular Perspective 54
Tgf-β1 transcriptionally promotes 90K expression: possible implications for cancer progression 54
Thyroglobulin repression of thyroid transcription factor 1 (TTF-1) gene expression is mediated by decreased DNA binding of nuclear factor I proteins which control constitutive TTF-1 expression 53
Current challenges in HER2-positive breast cancer 52
Breast cancer follow-up strategies in randomized phase III adjuvant clinical trials: a systematic review 48
Phenotypic and proteomic analysis identifies hallmarks of blood circulating extracellular vesicles in NSCLC responders to immune checkpoint inhibitors 48
Relationships between daily physical activity combinations and psychophysical health status of Italian breast cancer survivors 48
High blood concentration of circulating cancer stem cell-derived extracellular vesicles is associated with poor survival in advanced colorectal cancer patients 47
High Blood Concentration of Leukocyte-Derived Extracellular Vesicles Is Predictive of Favorable Clinical Outcomes in Patients with Pancreatic Cancer: Results from a Multicenter Prospective Study 45
Eribulin in triple negative metastatic breast cancer: Critic interpretation of current evidence and projection for future scenarios 44
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: An insight from clinical practice 42
Pretreatment neutrophil-lymphocyte ratio (NLR) predicted overall survival (OS) for metastatic melanoma, non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC) patients who received monotherapy with immune checkpoint inhibitor as ipilimumab, nivolumab and pembrolizumab 42
Whole breast radiotherapy in cN0 early breast cancer patients with pathological sentinel lymph nodes (pN1mic, pN1a) without axillary dissection: preliminary results of the observational LISEN trial 42
Prognostic value of gender and primary tumor location in metastatic colon cancer 42
Predictive Ability for Disease-Free Survival of the GRade, Age, Nodes, and Tumor (GRANT) Score in Patients with Resected Renal Cell Carcinoma 40
Circulating autoantibodies to LGALS3BP: a novel biomarker for cancer 37
Detection of Germline Mutations in a Cohort of 250 Relatives of Mutation Carriers in Multigene Panel: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2 36
Totale 7.230
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.625
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.625
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020547 0 0 0 0 0 0 121 87 94 111 127 7
2020/2021605 97 8 99 9 36 114 18 19 41 61 40 63
2021/2022557 19 15 5 118 34 32 15 46 33 15 62 163
2022/20231.842 143 236 160 191 190 329 98 155 210 16 70 44
2023/20241.029 86 31 66 44 64 329 173 30 41 33 25 107
2024/20251.141 137 390 324 109 61 118 2 0 0 0 0 0
Totale 7.663